The conference call can be accessed by dialing 866-295-6002 toll-free in the U.S. or 412-455-6209 for participants outside the U.S. (passcode: 86655088). The live audio webcast can be accessed on the Investor Relations section of the XBiotech website at www.investors.xbiotech.com. A replay of the call will be available on XBiotech's website for 90 days.

This Form 8-K and the related press release contains forward-looking statements, including declarations regarding management's beliefs and expectations, that involve substantial risks and uncertainties. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "would," "could," "expects," "plans," "contemplate," "anticipates," "believes," "estimates," "predicts," "projects," "intend" or "continue" or the negative of such terms or other comparable terminology, although not all forward-looking statements contain these identifying words. Forward-looking statements are subject to inherent risks and uncertainties in predicting future results and conditions that could cause the actual results to differ materially from those projected in these forward-looking statements. These risks and uncertainties are subject to the disclosure set forth in "Risk Factors" in our SEC filings.